{"id":772365,"date":"2023-07-25T16:37:45","date_gmt":"2023-07-25T20:37:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/"},"modified":"2023-07-25T16:37:45","modified_gmt":"2023-07-25T20:37:45","slug":"aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/","title":{"rendered":"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET"},"content":{"rendered":"
\n

WARREN, N.J., July 25, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), (the \u201cCompany\u201d or \u201cAquestive\u201d), a pharmaceutical company advancing medicines to solve patients\u2019 problems with current standards of care and provide transformative products to improve their lives, today announced that it will report results for the second quarter ended June 30, 2023, and provide an update on recent developments in its business after market close on Monday, August 7, 2023.<\/p>\n

Management will host a conference call for investors at 8:00 a.m. ET on Tuesday, August 8, 2023. In order to participate, please register in advance here<\/a> to obtain a local or toll-free phone number and your personal pin.<\/p>\n

A live webcast of the call will be available on Aquestive\u2019s website at: Second Quarter 2023 Earnings Conference Call<\/a><\/p>\n

Following the call, a replay of the webcast will be available on the Investors section of the Company\u2019s website at https:\/\/investors.aquestive.com\/events-and-presentations<\/a>. The webcast will be archived for 30 days.<\/p>\n

\n About Aquestive<\/strong>
\n
Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to solve patients\u2019 problems with current standards of care and provide transformative products to improve their lives. We are developing orally administered products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies. Aquestive has five commercialized products marketed by its licensees in the U.S. and around the world, and is the exclusive manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm\u00ae, and has proven drug development and commercialization capabilities. Aquestive is advancing a late-stage proprietary product pipeline focused on treating diseases of the central nervous system and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. For more information, visit\u00a0Aquestive.com<\/a>\u00a0and follow us on LinkedIn.<\/p>\n

\n Forward-Looking Statement<\/strong>\n <\/p>\n

Certain statements in this press release include \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as \u201cbelieve,\u201d \u201canticipate,\u201d \u201cplan,\u201d \u201cexpect,\u201d \u201cestimate,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cwill,\u201d or the negative of those terms, and similar expressions, are intended to identify forward-looking statements.<\/p>\n

These forward-looking statements are based on the Company\u2019s current expectations and beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such risks and uncertainties include, but are not limited to, risks associated with the Company\u2019s development work, including any delays or changes to the timing, cost and success of the Company\u2019s product development activities and clinical trials, and other risks and uncertainties affecting the Company described in the \u201cRisk Factors\u201d section and in other sections included in its Annual Report on Form 10-K, in its Quarterly Reports on Form 10-Q, and in its Current Reports on Form 8-K filed with the Securities and Exchange Commission. Given those uncertainties, you should not place undue reliance on these forward-looking statements, which speak only as of the date made. All subsequent forward-looking statements attributable to the Company or any person acting on its behalf are expressly qualified in their entirety by this cautionary statement. The Company assumes no obligation to update forward-looking statements or outlook or guidance after the date of this press release whether as a result of new information, future events or otherwise, except as may be required by applicable law.<\/p>\n

PharmFilm\u00ae\u00a0and the Aquestive logo are registered trademarks of Aquestive Therapeutics, Inc.<\/p>\n

\n Investor Inquiries<\/strong>
\n
ICR Westwicke
Stephanie Carrington
stephanie.carrington@westwicke.com<\/a>\u00a0
646-277-1282<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

WARREN, N.J., July 25, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), (the \u201cCompany\u201d or \u201cAquestive\u201d), a pharmaceutical company advancing medicines to solve patients\u2019 problems with current standards of care and provide transformative products to improve their lives, today announced that it will report results for the second quarter ended June 30, 2023, and provide an update on recent developments in its business after market close on Monday, August 7, 2023. Management will host a conference call for investors at 8:00 a.m. ET on Tuesday, August 8, 2023. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webcast of the call will be available on … <\/p>\n

Continue reading “Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-772365","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WARREN, N.J., July 25, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), (the \u201cCompany\u201d or \u201cAquestive\u201d), a pharmaceutical company advancing medicines to solve patients\u2019 problems with current standards of care and provide transformative products to improve their lives, today announced that it will report results for the second quarter ended June 30, 2023, and provide an update on recent developments in its business after market close on Monday, August 7, 2023. Management will host a conference call for investors at 8:00 a.m. ET on Tuesday, August 8, 2023. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webcast of the call will be available on … Continue reading "Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-25T20:37:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDUyNSM1NzA4NzY4IzIxMDAwOTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET\",\"datePublished\":\"2023-07-25T20:37:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/\"},\"wordCount\":606,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDUyNSM1NzA4NzY4IzIxMDAwOTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/\",\"name\":\"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDUyNSM1NzA4NzY4IzIxMDAwOTc=\",\"datePublished\":\"2023-07-25T20:37:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDUyNSM1NzA4NzY4IzIxMDAwOTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDUyNSM1NzA4NzY4IzIxMDAwOTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/","og_locale":"en_US","og_type":"article","og_title":"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET - Market Newsdesk","og_description":"WARREN, N.J., July 25, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), (the \u201cCompany\u201d or \u201cAquestive\u201d), a pharmaceutical company advancing medicines to solve patients\u2019 problems with current standards of care and provide transformative products to improve their lives, today announced that it will report results for the second quarter ended June 30, 2023, and provide an update on recent developments in its business after market close on Monday, August 7, 2023. Management will host a conference call for investors at 8:00 a.m. ET on Tuesday, August 8, 2023. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webcast of the call will be available on … Continue reading \"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-25T20:37:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDUyNSM1NzA4NzY4IzIxMDAwOTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET","datePublished":"2023-07-25T20:37:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/"},"wordCount":606,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDUyNSM1NzA4NzY4IzIxMDAwOTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/","name":"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDUyNSM1NzA4NzY4IzIxMDAwOTc=","datePublished":"2023-07-25T20:37:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDUyNSM1NzA4NzY4IzIxMDAwOTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDUyNSM1NzA4NzY4IzIxMDAwOTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aquestive-therapeutics-to-report-second-quarter-2023-financial-results-and-recent-business-highlights-on-august-7-and-host-conference-call-on-august-8-at-800-a-m-et\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=772365"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772365\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=772365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=772365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=772365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}